Meningococcal carriage and immunity in western Burkina Faso, 2003

Seydou Yaro; Yves Traoré; Zekiba Tarnagda; Lassana Sangaré; Berthe Marie NjanpopLafourcade; Aly Drabo; Helen Findlow; Raymond Borrow; Pierre Nicolas; Bradford D. Gessner; Judith E. Mueller

doi:10.1016/j.vaccine.2007.04.039

Meningococcal carriage and immunity in western Burkina Faso, 2003

Seydou Yaro, Yves Traoré, Zekiba Tarnagda, Lassana Sangaré, Berthe Marie NjanpopLafourcade, Aly Drabo, Helen Findlow, Raymond Borrow, Pierre Nicolas, Bradford D. Gessner, Judith E. Mueller^*

^*Corresponding author for this work

Manchester Meningococcal Reference Unit General

Research output: Contribution to journal › Article › peer-review

6 Citations (Scopus)

Abstract

A prospective carriage and serological study was conducted in Burkina Faso during the 2003 meningitis season, which was characterized by hyperendemic Neisseria meningitidis serogroup W135 (NmW135) and serogroup A (NmA) disease. Participants were evaluated five times at monthly intervals. In the presence of moderate NmW135 carriage, we found a low prevalence of putatively protective levels of specific immunoglobulin G (IgG) and serum bactericidal antibody (SBA) against NmW135. Specific IgG concentrations and SBA titers against NmA were relatively high in this recently vaccinated population, while no NmA carriage was detected. NmW135 carriage infrequently induced protective immunity against reference or homologous strains, while natural immunity against NmW135 was frequently lost. A vaccine that is effective against W135 will be beneficial for sub-Saharan Africa.

Original language	English
Pages (from-to)	A42-A46
Journal	Vaccine
Volume	25
Issue number	SUPPL. 1
DOIs	https://doi.org/10.1016/j.vaccine.2007.04.039
Publication status	Published - 3 Sept 2007

Bibliographical note

Funding Information:
This work was supported by the Institut Pasteur and the Bill and Melinda Gates Foundation. The authors would like to thank the participants, the direction of the sanitary region of Bobo-Dioulasso, the field team under coordination and supervision of Ahmed Djihoud, Regina Idohou and Paulin Somda, and Florent Ky, Issaka Yougbaré, Oumarou Sanou and Maxime Kienou who led the laboratory work. Special acknowledgments are given to Isabelle Parent du Châtelet, Brian Greenwood, Arnaud Fontanet, and Montserrat Soriano-Gabarro for scientific advice.

Keywords

Carriage
Immunity
Neisseria meningitidis

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.vaccine.2007.04.039

Cite this

@article{6d680b558059425291bbdb14e6aab0a1,

title = "Meningococcal carriage and immunity in western Burkina Faso, 2003",

abstract = "A prospective carriage and serological study was conducted in Burkina Faso during the 2003 meningitis season, which was characterized by hyperendemic Neisseria meningitidis serogroup W135 (NmW135) and serogroup A (NmA) disease. Participants were evaluated five times at monthly intervals. In the presence of moderate NmW135 carriage, we found a low prevalence of putatively protective levels of specific immunoglobulin G (IgG) and serum bactericidal antibody (SBA) against NmW135. Specific IgG concentrations and SBA titers against NmA were relatively high in this recently vaccinated population, while no NmA carriage was detected. NmW135 carriage infrequently induced protective immunity against reference or homologous strains, while natural immunity against NmW135 was frequently lost. A vaccine that is effective against W135 will be beneficial for sub-Saharan Africa.",

keywords = "Carriage, Immunity, Neisseria meningitidis",

author = "Seydou Yaro and Yves Traor{\'e} and Zekiba Tarnagda and Lassana Sangar{\'e} and NjanpopLafourcade, {Berthe Marie} and Aly Drabo and Helen Findlow and Raymond Borrow and Pierre Nicolas and Gessner, {Bradford D.} and Mueller, {Judith E.}",

note = "Funding Information: This work was supported by the Institut Pasteur and the Bill and Melinda Gates Foundation. The authors would like to thank the participants, the direction of the sanitary region of Bobo-Dioulasso, the field team under coordination and supervision of Ahmed Djihoud, Regina Idohou and Paulin Somda, and Florent Ky, Issaka Yougbar{\'e}, Oumarou Sanou and Maxime Kienou who led the laboratory work. Special acknowledgments are given to Isabelle Parent du Ch{\^a}telet, Brian Greenwood, Arnaud Fontanet, and Montserrat Soriano-Gabarro for scientific advice.",

year = "2007",

month = sep,

day = "3",

doi = "10.1016/j.vaccine.2007.04.039",

language = "English",

volume = "25",

pages = "A42--A46",

journal = "Vaccine",

issn = "0264-410X",

publisher = "Elsevier Ltd.",

number = "SUPPL. 1",

}

TY - JOUR

T1 - Meningococcal carriage and immunity in western Burkina Faso, 2003

AU - Yaro, Seydou

AU - Traoré, Yves

AU - Tarnagda, Zekiba

AU - Sangaré, Lassana

AU - NjanpopLafourcade, Berthe Marie

AU - Drabo, Aly

AU - Findlow, Helen

AU - Borrow, Raymond

AU - Nicolas, Pierre

AU - Gessner, Bradford D.

AU - Mueller, Judith E.

N1 - Funding Information: This work was supported by the Institut Pasteur and the Bill and Melinda Gates Foundation. The authors would like to thank the participants, the direction of the sanitary region of Bobo-Dioulasso, the field team under coordination and supervision of Ahmed Djihoud, Regina Idohou and Paulin Somda, and Florent Ky, Issaka Yougbaré, Oumarou Sanou and Maxime Kienou who led the laboratory work. Special acknowledgments are given to Isabelle Parent du Châtelet, Brian Greenwood, Arnaud Fontanet, and Montserrat Soriano-Gabarro for scientific advice.

PY - 2007/9/3

Y1 - 2007/9/3

N2 - A prospective carriage and serological study was conducted in Burkina Faso during the 2003 meningitis season, which was characterized by hyperendemic Neisseria meningitidis serogroup W135 (NmW135) and serogroup A (NmA) disease. Participants were evaluated five times at monthly intervals. In the presence of moderate NmW135 carriage, we found a low prevalence of putatively protective levels of specific immunoglobulin G (IgG) and serum bactericidal antibody (SBA) against NmW135. Specific IgG concentrations and SBA titers against NmA were relatively high in this recently vaccinated population, while no NmA carriage was detected. NmW135 carriage infrequently induced protective immunity against reference or homologous strains, while natural immunity against NmW135 was frequently lost. A vaccine that is effective against W135 will be beneficial for sub-Saharan Africa.

AB - A prospective carriage and serological study was conducted in Burkina Faso during the 2003 meningitis season, which was characterized by hyperendemic Neisseria meningitidis serogroup W135 (NmW135) and serogroup A (NmA) disease. Participants were evaluated five times at monthly intervals. In the presence of moderate NmW135 carriage, we found a low prevalence of putatively protective levels of specific immunoglobulin G (IgG) and serum bactericidal antibody (SBA) against NmW135. Specific IgG concentrations and SBA titers against NmA were relatively high in this recently vaccinated population, while no NmA carriage was detected. NmW135 carriage infrequently induced protective immunity against reference or homologous strains, while natural immunity against NmW135 was frequently lost. A vaccine that is effective against W135 will be beneficial for sub-Saharan Africa.

KW - Carriage

KW - Immunity

KW - Neisseria meningitidis

UR - http://www.scopus.com/inward/record.url?scp=34547650985&partnerID=8YFLogxK

U2 - 10.1016/j.vaccine.2007.04.039

DO - 10.1016/j.vaccine.2007.04.039

M3 - Article

C2 - 17559988

AN - SCOPUS:34547650985

SN - 0264-410X

VL - 25

SP - A42-A46

JO - Vaccine

JF - Vaccine

IS - SUPPL. 1

ER -

Meningococcal carriage and immunity in western Burkina Faso, 2003

Abstract

Bibliographical note

Keywords

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this